AF
Allworth Financial Portfolio holdings
AUM
$20.8B
1-Year Return
12.38%
This Quarter Return
+7.71%
1 Year Return
+12.38%
3 Year Return
+38.45%
5 Year Return
+53.41%
10 Year Return
+94.66%
AUM
$20.8B
AUM Growth
+$3.11B
(+18%)
Cap. Flow
+$1.67B
Cap. Flow
% of AUM
8.03%
Top 10 Holdings %
Top 10 Hldgs %
49.36%
Holding
4,689
New
639
Increased
2,505
Reduced
743
Closed
112
Top Buys
| 1 |
Apple
AAPL
|
+$116M |
| 2 |
NVIDIA
NVDA
|
+$103M |
| 3 |
Vanguard Total Stock Market ETF
VTI
|
+$47.5M |
| 4 |
Microsoft
MSFT
|
+$35M |
| 5 |
Dimensional US Core Equity 2 ETF
DFAC
|
+$34.7M |
Top Sells
Sector Composition
| 1 | Technology | 6.68% |
| 2 | Financials | 2.92% |
| 3 | Healthcare | 1.88% |
| 4 | Industrials | 1.82% |
| 5 | Consumer Discretionary | 1.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
3776
GCM Grosvenor
GCMG
$681M
| $1.69K | ﹤0.01% |
146
-16
| -10% | -$185 |
|
3777
iShares MSCI Philippines ETF
EPHE
$104M
| $1.68K | ﹤0.01% |
62
| – | – |
|
3778
Sunstone Hotel Investors
SHO
$1.76B
| $1.67K | ﹤0.01% |
192
-57
| -23% | -$495 |
|
3779
Idaho Strategic Resources
IDR
$408M
| $1.66K | ﹤0.01% |
+127
| New | +$1.66K |
|
3780
Kymera Therapeutics
KYMR
$3.11B
| $1.66K | ﹤0.01% |
38
-14
| -27% | -$611 |
|
3781
Talkspace
TALK
$427M
| $1.66K | ﹤0.01% |
595
+195
| +49% | +$542 |
|
3782
Pebblebrook Hotel Trust
PEB
$1.36B
| $1.65K | ﹤0.01% |
165
-1,065
| -87% | -$10.6K |
|
3783
Mission Produce
AVO
$829M
| $1.64K | ﹤0.01% |
140
+14
| +11% | +$164 |
|
3784
Quantum-Si Incorporated
QSI
$227M
| $1.64K | ﹤0.01% |
836
| – | – |
|
3785
Sotera Health
SHC
$4.47B
| $1.64K | ﹤0.01% |
147
-11
| -7% | -$122 |
|
3786
Aura Biosciences
AURA
$400M
| $1.63K | ﹤0.01% |
261
+195
| +295% | +$1.22K |
|
3787
Rush Enterprises Class B
RUSHB
$4.4B
| $1.63K | ﹤0.01% |
31
+24
| +343% | +$1.26K |
|
3788
S&T Bancorp
STBA
$1.49B
| $1.63K | ﹤0.01% |
43
+20
| +87% | +$757 |
|
|
NNDM
3789
Nano Dimension
NNDM
$311M
| $1.62K | ﹤0.01% |
1,000
| – | – |
|
3790
SPDR Portfolio Europe ETF
SPEU
$694M
| $1.61K | ﹤0.01% |
33
| – | – |
|
3791
Allogene Therapeutics
ALLO
$246M
| $1.61K | ﹤0.01% |
1,423
+1,083
| +319% | +$1.22K |
|
3792
MannKind Corp
MNKD
$1.71B
| $1.61K | ﹤0.01% |
429
+218
| +103% | +$816 |
|
3793
Rani Therapeutics
RANI
$23.3M
| $1.6K | ﹤0.01% |
3,119
| – | – |
|
|
SAIL
3794
SailPoint, Inc. Common Stock
SAIL
$11B
| $1.6K | ﹤0.01% |
+70
| New | +$1.6K |
|
3795
Vertex
VERX
$3.81B
| $1.59K | ﹤0.01% |
45
-32
| -42% | -$1.13K |
|
3796
Open Lending Corp
LPRO
$253M
| $1.59K | ﹤0.01% |
+817
| New | +$1.59K |
|
|
MESO
3797
Mesoblast
MESO
$1.99B
| $1.58K | ﹤0.01% |
+145
| New | +$1.58K |
|
3798
CTS Corp
CTS
$1.22B
| $1.58K | ﹤0.01% |
37
+6
| +19% | +$256 |
|
3799
Atlanta Braves Holdings Series A
BATRA
$2.84B
| $1.58K | ﹤0.01% |
32
+16
| +100% | +$788 |
|
3800
Luxfer Holdings
LXFR
$358M
| $1.57K | ﹤0.01% |
+129
| New | +$1.57K |
|